Compendium of inflammatory diseases / Michael J. Parnham, editor-in-chief.

Adhesion molecules of neutrophils
Anaphylaxis (Immediate hypersensitivity): from old to new mechanisms
Antiviral Responses
Autophagy and Inflammation
Basophils
Cell signalling in neutrophils
Co-stimulatory Receptors
Dendritic Cells
GILZ-Related Regulation of Inflammation
Glial Cells
Immunoglobulin receptors and inflammation.-Inflammation and autoimmunity
Inflammatory Bowel Disease Models in Animals
Leukocyte Recruitment
Lymphocyte homing and trafficking
Macrophage heterogeneity during inflammation
Mast Cells
Mechanisms of Macrophage Migration in 3-Dimensional Environments
Microvascular Responses to Inflammation
Modulation of inflammation by key nutrials
Natural Killer Cells
Neutrophil Extracellular Traps
Neutrophil oxidative burst
Obesity and Inflammation
Osteoclasts in Inflammation
Parasitism: A Unique Lifestyle Reflecting Dynamic Parasite- and Host(s)-Co-driven Processes
Platelet, Endothelium, and Inflammation
Regulatory T cells
Sepsis Models in Animals
Skin inflammation models in animals
Th17 Response
Toll-Like Receptors
Angiogenesis Inhibitors
Anti-asthma Drugs, Overview
Anti-histamines
Anti-muscarinics
Antibiotics as anti-inflammatory drugs
Antimalarial Drugs
Azathioprine/Thiopurines
Beta2 Agonists
CD 20 Inhibitors
Rituximab
CD80/86 Inhibitors
Chromones
Cromoglycate and Nedocromil
Colony stimulating factor therapeutics
Corticosteroids
Coxibs
Disease-Modifying Anti-Rheumatic Drugs
Fenamates
Flavonoids as anti-inflammatory agents
Gold Complexes
Interleukin 1 Inhibitors
Interleukin 12/23 Inhibitors: Ustekinumab Interleukin-6 Inhibitor
Tocilizumab
Leflunomide
Medicinal Fatty Acids
Methotrexate.-NO-donating anti-inflammatory drugs
Non-steroidal anti-inflammatory drugs
Phosphodiesterase-4 inhibitors
Propionic Acid Derivative Drugs (Profens)
Salicylates
Sulfasalazine and Related Drugs
Tetracyclines
Theophylline
TNF Inhibitors
Acute exacerbations of airway inflammation
Allergic Disorders
Alzheimer's Disease
Antiphospholipid antibody syndrome
Asthma
Atopic dermatitis
Autoinflammatory syndromes
Behcet's disease
Bronchiolitis obliterans
Cancer and inflammation
Cogan's syndrome
COPD
Diabetes type I
Diabetes type II
Diffuse panbronchiolitis
Gaucher's disease
Genetic susceptibility to inflammatory diseases
Gout
Graft vs Host Disease
Granulomatosis with Polyangiitis (GPA)
Grave's disease.-Guillaine-Barre disease
Henoch-Schönlein Purpura
Idiopathic Thrombocytopenic Purpura
Inflammatory bowel disease
Juvenile idiopathic arthritis
Kawasaki Disease
Lyme disease
Osteoarthritis.-Osteoarthritis Genetics
Polymyositis and Dermatomyositis
Rheumatic Fever
Rheumatoid arthritis
Role of Cell Therapy in Autoimmune Disease
Sarcoidosis
Sepsis
Spondylarthropathies
ACKR3
Adhesion molecules
Alarmins
Antibacterial Host .-Defense Peptides
Bacterial Lipopolysaccharide.-Biofilm
Bone Morphogenetic Proteins in Inflammation
C5a Receptors
CCL18
CCR1
Ceramide 1-Phosphate: A Mediator of Inflammatory Responses
Complement System
CXCL4 und CXCL4L1
CXCR1 and CXCR2 and Ligands
CXCR3 and its Ligands
Cytokines
Cytolytic Granules
Foxp3
Heat Shock Proteins
Histamine
IFNgamma
IkappaB
Inflammasomes
Interleukin 1
Interleukin 10
Interleukin 12
Interleukin 17
Interleukin 18
Interleukin 18 Binding Protein
Interleukin 2
Interleukin 22
Interleukin 23
Interleukin 27
Interleukin 32
Interleukin 36 Cytokines
Interleukin 4 and the related cytokines (Interleukin 5 and Interleukin 13)
Interleukin 6
Interleukin 9
Interleukin-33
Janus Kinases (JAKs)/STAT Pathway
Kinins
Leukotrienes
Mammalian Target of Rapamycin (mTOR)
MAP Kinase Pathways
NFkappaB
Nitric oxide
Nuclear Receptor Signaling in the Control of Inflammation
Pathogen-Associated Molecular Patterns (PAMPs)
Pentraxins
Prostanoids
Protease-Activated Receptors
Reactive oxygen species
Substance P in Inflammation
TGF-b superfamily cytokine MIC-1/GDF15 in health and inflammatory diseases
TNFalpha
Type I Interferons.